Beware of fake advertisements on social media using the SGH logo to promote products. SGH does NOT promote, advertise, or endorse any particular brand or product in accordance with the Healthcare Services Act. Stay vigilant and ignore these fake advertisements.

Singapore uses mass spectrometry to diagnose hypertension for the first time
28 Jan 2021 | Lianhe Zaobao

28 January 2021 - The Shimadzu-CGH Clinomics Centre (SC3) which will allow doctors to offer personalised treatment of patients with chronic diseases such as hypertension was officially opened on 27 January 2021.

The Centre uses technology called liquid chromatography coupled with tandem mass spectrometry that can accurately analyse clinical samples.

This will help doctors tailor more individualised treatment instead of taking a one-size-fits all approach.

SOURCE: LIANHE ZAOBAO SINGAPORE PRESS HOLDINGS LIMITED, REPRODUCED WITH PERMISSION

20210128_LHZB_Singapore uses mass spectrometry to diagnose hypertension for the first time (C).pdf

Chinese

20210128_LHZB_Singapore uses mass spectrometry to diagnose hypertension for the first time (C).pdf

Download (490.8 KB)